Increasing incidence of non-Hodgkin's lymphoma in Canada, 1970-1996: Age-period-cohort analysisSHILIANG LIU; SEMENCIW, Robert; YANG MAO et al.Hematological oncology. 2003, Vol 21, Num 2, pp 57-66, issn 0278-0232, 10 p.Article

Psychosomatic liaison service in hematological oncology: Need for psychotherapeutic interventions and their realizationFRITZSCHE, Kurt; STRUSS, Yvonne; STEIN, Barbara et al.Hematological oncology. 2003, Vol 21, Num 2, pp 83-89, issn 0278-0232, 7 p.Article

T cells in myelomaRAITAKARI, M; BROWN, R. D; GIBSON, J et al.Hematological oncology. 2003, Vol 21, Num 1, pp 33-42, issn 0278-0232, 10 p.Article

Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapyLITTLEWOOD, Timothy J; NORTIER, Johan; RAPOPORT, Bernardo et al.Hematological oncology. 2003, Vol 21, Num 4, pp 169-180, issn 0278-0232, 12 p.Article

Mitoxantrone-cyclophosphamide-rituximab: An effective and safe combination for indolent NHLEMMANOUILIDES, C; TERRITO, M; MENCO, H et al.Hematological oncology. 2003, Vol 21, Num 3, pp 99-108, issn 0278-0232, 10 p.Article

A comparison of normal and leukemic stem cell biology in chronic myeloid leukemiaJØRGENSEN, Heather G; HOLYOAKE, Tessa L.Hematological oncology. 2001, Vol 19, Num 3, pp 89-106, issn 0278-0232Article

Hairy cell leukemia in Hong Kong Chinese : A 12-year retrospective surveyAU, W. Y; KWONG, Y. L; LIANG, R et al.Hematological oncology. 2000, Vol 18, Num 4, pp 155-159, issn 0278-0232Article

Uncommon patterns of presentation of leukemiaVIDAL, C; BAER, M. R; BLOOMFIELD, C. D et al.Hematological oncology. 1999, Vol 17, Num 1, pp 11-29, issn 0278-0232Article

Clinical and biological applications of image analysis in non-Hodgkin's lymphomasCANZONIERI, V; CARBONE, A.Hematological oncology. 1998, Vol 16, Num 1, pp 15-28, issn 0278-0232Article

Circulating CD34⁺ counts and apheresis planningAUER, R. L; HOLTOM, P; SMITH, H et al.Hematological oncology. 1998, Vol 16, Num 2, pp 69-75, issn 0278-0232Article

Engraftment of chronic myeloid leukemia in SCID miceHOYLE, C. F; NEGRIN, R. S.Hematological oncology. 1998, Vol 16, Num 3, pp 87-100, issn 0278-0232Article

Improved treatment outcome in adult acute lymphoblastic leukemia using the intensive German protocol, a preliminary reportCHIM, C. S; KWONG, Y. L; CHU, Y. C et al.Hematological oncology. 1997, Vol 15, Num 1, pp 19-26, issn 0278-0232Article

12-O-tetradecanoylphorbol-13-acetate (TPA) downregulates expression of CD30 in erythroleukemia cell line K562EZAWA, H; HARIGAYA, K; ISHII, G et al.Hematological oncology. 1997, Vol 15, Num 3, pp 151-161, issn 0278-0232Article

Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patientsBAIREY, O; GABBAY, L; BLICKSTEIN, D et al.Hematological oncology. 1997, Vol 15, Num 3, pp 121-127, issn 0278-0232Article

T-cell derived cytokines co-stimulate proliferation of CD40-activated germinal centre as well as follicular lymphoma cellsSCHMITTER, D; KOSS, M; NIEDERER, E et al.Hematological oncology. 1997, Vol 15, Num 4, pp 197-207, issn 0278-0232Article

A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (R-MeTHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma NHLSMITH, G. M; CHILD, J. A; CULLEN, M. H et al.Hematological oncology. 1996, Vol 14, Num 4, pp 193-201, issn 0278-0232Article

Primary B cell lymphoma of the mediastinumCHIM, C. S; LIANG, R; CHAN, A. C. L et al.Hematological oncology. 1996, Vol 14, Num 4, pp 173-179, issn 0278-0232Article

Interleukin-10 production by a B-cell line derived from human post-transplant lymphoproliferative diseasePARMJEET RANDHAWA; NALESNIK, M; DEMETRIS, J et al.Hematological oncology. 1995, Vol 13, Num 1, pp 13-18, issn 0278-0232Article

Multiple myeloma : an immunoclinical study of disease and response to treatmentTHAVASU, P. W; GANJOO, R. K; MAIDMENT, S. A et al.Hematological oncology. 1995, Vol 13, Num 2, pp 69-82, issn 0278-0232Article

Potential role for low dose limited-field radiation therapy (2×2 grays) in advanced low-grade non-hodgkin's lymphomasGANEM, G; LAMBIN, P; SOCIE, G et al.Hematological oncology. 1994, Vol 12, Num 1, pp 1-8, issn 0278-0232Article

Evidence of colony suppressor activity and deficiency of hematopoietic growth factors in hairy cell leukemiaGASCHE, C; REINISCH, W; SCHWARZMEIER, J. D et al.Hematological oncology. 1993, Vol 11, Num 2, pp 97-104, issn 0278-0232Article

Post-transcriptional regulation of interferon-alpha 4 subtype production by lymphoblastoid cellsGREENWAY, A. L; BRANDT, E. R; HERTZOG, P. J et al.Hematological oncology. 1993, Vol 11, Num 1, pp 7-21, issn 0278-0232Article

Reinforced HEAV'D therapy for adult acute lymphoblastic leukemia: improved results and revised prognostic criteriaBASSAN, R; BATTISTA, R; MONTALDI, A et al.Hematological oncology. 1993, Vol 11, Num 4, pp 169-177, issn 0278-0232Article

Restriction of T cell receptor variable region in lymph nodes of adult T cell leukemia/lymphomaOHSHIMA, K; KIKUCHI, M; YONEDA, S et al.Hematological oncology. 1993, Vol 11, Num 3, pp 147-154, issn 0278-0232Article

Comparative pharmacokinetic study of idarubicin and daunorubicin in leukemia patientsROBERT, J; RIGAL-HUGUET, F; HURTELOUP, P et al.Hematological oncology. 1992, Vol 10, Num 2, pp 111-116, issn 0278-0232Article